Erschienen in:
24.12.2022 | EDITORIAL
68Ga-DOTATATE PET/CT for assessment of cardiac sarcoidosis: hidden opportunities?
verfasst von:
Andrea G. Monroy-Gonzalez, MD, PhD, Paola A. Erba, MD, PhD, Riemer H. J. A. Slart, MD, PhD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 3/2023
Einloggen, um Zugang zu erhalten
Excerpt
Diagnosis and treatment of cardiac sarcoidosis (CS) currently remain challenging with no imaging-based gold standard. MRI delineates scarring and edema but does not provide enough information about the immunological state of this granulomatous disease.
1 [
18F]FDG PET/CT, the gold standard for non-invasive cardiac inflammation, may be hindered by physiological myocardial uptake despite patient preparation (fasting, ketogenic diet, or heparin injection), resulting in low specificity.
1 Because somatostatin receptor has been identified in inflammatory cells, somatostatin analogues have been proposed as a potential alternative for different chronic inflammatory diseases.
2 …